CSPC Pharmaceutical GroupFRA:CVGU +3.88%88 Interest Coverage is 108.81 as of Dec. 2025, which is 20% below its 10-year median of 136.31. GuruFocus rates FRA:CVGU with a GF Score™ of 88/100 and a GF Value™ of €2.63. The stock has 4 warning signs investors should review. Among 684 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks better than 76.61% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. CSPC Pharmaceutical Group's
Operating Income
for the
three
months ended in Dec. 2025 was €89 Mil. CSPC Pharmaceutical Group's Interest Expense for the
three
months ended in Dec. 2025 was €-1 Mil.
CSPC Pharmaceutical Group's interest coverage for the quarter that ended in Dec. 2025 was 108.81.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. CSPC Pharmaceutical Group Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for CSPC Pharmaceutical Group's Interest Coverage or its related term are showing as below:
FRA:CVGU'
s Interest Coverage Range Over the Past 10 Years
Min: 51.43 Med: 136.31 Max: 815.43
Current: 85.11
FRA:CVGU's Interest Coverage is ranked better than 76.61% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs FRA:CVGU: 85.11
CSPC Pharmaceutical Group (FRA:CVGU) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
CSPC Pharmaceutical Group Interest Coverage Related Terms
CSPC Pharmaceutical Group Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:CVGU vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's Interest Coverage falls into.
CSPC Pharmaceutical Group Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (FRA:CVGU) has a Interest Coverage of 108.81 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CSPC Pharmaceutical Group and its competitors. This is 20% below median its historical median of 136.31. Over the past decade, CSPC Pharmaceutical Group's Interest Coverage has ranged from 51.43 to 815.43. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #160 out of 684 companies in the Drug Manufacturers industry, placing it in the top 23.4%.
Is CSPC Pharmaceutical Group's Interest Coverage too high?
CSPC Pharmaceutical Group's current Interest Coverage of 108.81 is 20% below median its 10-year median of 136.31. Over the past 10 years, this metric has ranged from a low of 51.43 to a high of 815.43. The Drug Manufacturers industry median Interest Coverage is 12.77. CSPC Pharmaceutical Group's value of 108.81 is 752.4% above this industry median. Based on the distribution chart, CSPC Pharmaceutical Group ranks #160 out of 684 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, CSPC Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #160 out of 684 companies for Interest Coverage. This places CSPC Pharmaceutical Group in the top 23% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.77. CSPC Pharmaceutical Group's value of 108.81 is 752.4% above this benchmark. Historically, CSPC Pharmaceutical Group's own Interest Coverage has ranged from 51.43 to 815.43 over the past decade. While the company's 10-year median is 136.31 vs. the industry median of 12.77, CSPC Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSPC Pharmaceutical Group's current Interest Coverage of 108.81 is 752.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current Interest Coverage is 108.81, which is 20% below median its own 10-year median of 136.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
CSPC Pharmaceutical Group (FRA:CVGU) has a current Interest Coverage of 108.81. The stock's GF Value™ is €2.63, compared to a current price of €2.68 — trading 1.9% above its estimated fair value. The current Interest Coverage is 108.81, which is 20% below median its 10-year median of 136.31 and 752.4% above the Drug Manufacturers industry median of 12.77. CSPC Pharmaceutical Group's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For CSPC Pharmaceutical Group (FRA:CVGU), the current Interest Coverage is 108.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSPC Pharmaceutical Group (FRA:CVGU) Overvalued in 2026?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued.
The current stock price of €2.68 is trading 1.9% above its estimated GF Value™ of €2.63.
Key valuation signals for FRA:CVGU:
Interest Coverage: 108.81 (20% below median its 10-year median of 136.31)
GF Value™: €2.63 vs. price of €2.68 (1.9% above fair value)
Industry Position: 752.4% above the Drug Manufacturers median (#160 of 684)
No single metric tells the full story. See the FRA:CVGU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
88GF Score
Get the complete analysis for FRA:CVGU
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CVGU has been successfully added to your 
